IGBMC
Massimo Lodi is a skilled professional in the field of medicine, currently serving as a breast surgeon at Hôpitaux Civils de Colmar since January 2024. Lodi has also held various research and academic positions at IGBMC since January 2018, contributing to the study of molecular and cellular biology of breast cancer under the guidance of Dr. Catherine Tomasetto. Prior experience includes a surgeon role at CHRU de Strasbourg and a fellowship in obstetrics and gynecology, alongside serving at ICANS as a surgeon. Lodi's extensive education includes multiple degrees from the University of Strasbourg, culminating in a PhD in Life and Health Sciences and a postgraduate degree in Surgical Oncology, as well as training in artificial intelligence in health and a background in obstetrics and gynecology.
This person is not in any teams
IGBMC
Created in 1994 by Pierre Chambon, one of the most important figures in biomedical research, the IGBMC is now one of the main European research centres in this domain. In France, it is the largest research unit, involving the CNRS, Inserm and the University of Strasbourg. In addition to its four scientific programs, the IGBMC has developed advanced scientific services and technological platforms for internal use, but also open to the wider scientific community. The Institute aims to develop interdisciplinary research at the interface of biology, biochemistry, physics and medicine, but also to attract students from around the world by offering very high-level education in the field of biomedical sciences. The IGBMC campus is located on the "Parc d'Innovation d'Illkirch" in the Strasbourg suburbs, which represents an exceptional scientific, academic and industrial environment and largely favours collaborations and technology transfer.